ATE112567T1 - Imidazo(4,5-c>pyridine als paf antagonisten. - Google Patents

Imidazo(4,5-c>pyridine als paf antagonisten.

Info

Publication number
ATE112567T1
ATE112567T1 AT91909431T AT91909431T ATE112567T1 AT E112567 T1 ATE112567 T1 AT E112567T1 AT 91909431 T AT91909431 T AT 91909431T AT 91909431 T AT91909431 T AT 91909431T AT E112567 T1 ATE112567 T1 AT E112567T1
Authority
AT
Austria
Prior art keywords
imidazo
pyridine
paf antagonist
paf
antagonist
Prior art date
Application number
AT91909431T
Other languages
English (en)
Inventor
Anthony Marfat
James Frederick Eggler
Kevin Cooper
Michael Jonathan Fray
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Application granted granted Critical
Publication of ATE112567T1 publication Critical patent/ATE112567T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pain & Pain Management (AREA)
  • Vascular Medicine (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Rheumatology (AREA)
  • Pulmonology (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
AT91909431T 1990-05-09 1991-05-01 Imidazo(4,5-c>pyridine als paf antagonisten. ATE112567T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US52119990A 1990-05-09 1990-05-09

Publications (1)

Publication Number Publication Date
ATE112567T1 true ATE112567T1 (de) 1994-10-15

Family

ID=24075786

Family Applications (1)

Application Number Title Priority Date Filing Date
AT91909431T ATE112567T1 (de) 1990-05-09 1991-05-01 Imidazo(4,5-c>pyridine als paf antagonisten.

Country Status (27)

Country Link
EP (1) EP0533695B1 (de)
JP (1) JPH0678340B2 (de)
CN (1) CN1057839A (de)
AP (1) AP224A (de)
AT (1) ATE112567T1 (de)
AU (1) AU642265B2 (de)
BR (1) BR9106433A (de)
CA (1) CA2080476A1 (de)
DE (1) DE69104481T2 (de)
DK (1) DK0533695T3 (de)
ES (1) ES2061247T3 (de)
FI (1) FI925053A0 (de)
GT (1) GT199100031A (de)
HU (1) HUT62894A (de)
IE (1) IE911553A1 (de)
IL (1) IL98075A0 (de)
MA (1) MA22151A1 (de)
MY (1) MY105512A (de)
NO (1) NO924290L (de)
NZ (1) NZ238089A (de)
PE (1) PE26691A1 (de)
PT (1) PT97616A (de)
RO (1) RO109450B1 (de)
TW (1) TW205549B (de)
WO (1) WO1991017163A1 (de)
YU (1) YU81191A (de)
ZA (1) ZA913497B (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9102997D0 (en) * 1991-02-13 1991-03-27 Pfizer Ltd Therapeutic agents
WO1994004537A2 (en) * 1992-08-20 1994-03-03 Cytomed, Inc. Dual functional anti-inflammatory and immunosuppressive agents
US6372770B1 (en) 1994-10-12 2002-04-16 Euro-Celtique, S.A. Benzoxazoles
US6232322B1 (en) 1998-05-12 2001-05-15 American Home Products Corporation Biphenyl oxo-acetic acids useful in the treatment of insulin resistance and hyperglycemia
CA2330557A1 (en) * 1998-05-12 1999-11-18 Robert Emmett Mcdevitt Biphenyl oxo-acetic acids useful in the treatment of insulin resistance and hyperglycemia
US6310081B1 (en) 1999-05-10 2001-10-30 American Home Products Corporation Biphenyl sulfonyl aryl carboxylic acids useful in the treatment of insulin resistance and hyperglycemia
GB0302094D0 (en) 2003-01-29 2003-02-26 Pharmagene Lab Ltd EP4 receptor antagonists
GB0324269D0 (en) 2003-10-16 2003-11-19 Pharmagene Lab Ltd EP4 receptor antagonists
EP3044210A4 (de) * 2013-09-13 2017-03-15 Cortendo AB (publ) Neuartige cytochrom-p450-hemmer und verfahren zur verwendung
CN105348182B (zh) * 2014-08-24 2018-04-13 复旦大学 2‑烷氧基苯甲酰芳胺类化合物及其药物用途

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES517193A0 (es) * 1981-11-10 1983-12-01 Wellcome Found Un procedimiento para la preparacion de nuevos derivados de imidazo (4,5-c)piridina.
GB8804439D0 (en) * 1988-02-25 1988-03-23 Pfizer Ltd Dihydropyridines
GB8822170D0 (en) * 1988-09-21 1988-10-26 Pfizer Ltd Therapeutic agents

Also Published As

Publication number Publication date
MY105512A (en) 1994-10-31
AU642265B2 (en) 1993-10-14
GT199100031A (es) 1992-10-30
CN1057839A (zh) 1992-01-15
TW205549B (de) 1993-05-11
AU7867191A (en) 1991-11-27
PT97616A (pt) 1992-03-31
IL98075A0 (en) 1992-06-21
RO109450B1 (ro) 1995-02-28
ES2061247T3 (es) 1994-12-01
DE69104481D1 (de) 1994-11-10
FI925053A (fi) 1992-11-06
EP0533695A1 (de) 1993-03-31
HUT62894A (en) 1993-06-28
DE69104481T2 (de) 1995-02-09
FI925053A0 (fi) 1992-11-06
WO1991017163A1 (en) 1991-11-14
IE911553A1 (en) 1991-11-20
BR9106433A (pt) 1993-05-04
CA2080476A1 (en) 1991-11-10
YU81191A (sh) 1994-06-10
ZA913497B (en) 1992-12-30
AP224A (en) 1992-10-27
JPH0678340B2 (ja) 1994-10-05
JPH05505619A (ja) 1993-08-19
DK0533695T3 (da) 1995-01-09
EP0533695B1 (de) 1994-10-05
MA22151A1 (fr) 1991-12-31
NO924290D0 (no) 1992-11-06
HU9203496D0 (en) 1993-01-28
PE26691A1 (es) 1991-10-21
NO924290L (no) 1992-11-06
NZ238089A (en) 1992-10-28
AP9100259A0 (en) 1991-07-31

Similar Documents

Publication Publication Date Title
DE59100656D1 (de) Bohrfutter.
DE59101925D1 (de) Bohrfutter.
DE59104722D1 (de) Drehmaschine.
DE69108784T2 (de) Schlüsselloses Spannfutter.
MX9202838A (es) Imidazo[1,5-a]quinoxalinas.
DE69204906T2 (de) 2-Hydroxy-2-phenylethylaminderivate als Beta-3-adrenoceptor Agonisten.
DE3877491T2 (de) Polysaccharid-/perfluoralkyl-komplexverbindungen.
FI913048A0 (fi) Bicykliska heterocykliska foereningar.
ITTO910865A1 (it) Composti triciclici.
ATE112567T1 (de) Imidazo(4,5-c>pyridine als paf antagonisten.
ATE116980T1 (de) Verbesserungen an leukotrien-antagonieten.
DE3575926D1 (de) 1,6-naphthyridin-2(1h)-one brauchbar als kardiotonika.
FI913182A0 (fi) Tricykliska foereningar innehaollande heteroatomer.
ITTO920650A1 (it) Gruppo integrato di fertirrigazione.
NO895217D0 (no) Substituerte pyrido(2,3-d)pyrimidiner.
DE59005205D1 (de) Aufzugseinrichtung.
IT234656Y1 (it) Gruppo costruttivo per cassetti.
KR950700297A (ko) 5-HT3-수용체 길항제로서의 2,6-메타노-2H-퀴놀리진 유도체(2,6-Methano-2H-quinolizin derivative as 5-HT3-receptor antagonist)
DE69109538T2 (de) Kompakt-Mehrzweckepiskop.
DOP1993004907A (es) Nuevos agentes nematicidas.
DE59103481D1 (de) o-Aminoazoverbindungen.
NO911833D0 (no) Gulvsluk.
DE59104042D1 (de) Chlorphenylalkoxyalkyl-Verbindungen.
NO913383D0 (no) Katamaran.
NO912295D0 (no) Katamaran.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee